Skip to content
AkademScholar

Products

For developers

AkademBasesoonDeveloper API
Authors

Philipp du Cros

Last known institution:
Médecins Sans Frontières
ORCID:
0000-0002-3599-029X
4
h-index
1
i10-index
48
Citations
20
Works
Trends over time

Performance over time

Citation overview

Publications (bars) and citations (line) by year

  • Publications
  • Citations
0120510152020172018201920202021202220232024202520262017: Publications 1, Citations 12018: Publications 2, Citations 12019: Publications 1, Citations 22020: Publications 1, Citations 122021: Publications 0, Citations 142022: Publications 2, Citations 12023: Publications 0, Citations 12024: Publications 0, Citations 32025: Publications 0, Citations 22026: Publications 0, Citations 2

Citation history

0510152020172018201920202021202220232024202520262017: Citations 12018: Citations 12019: Citations 22020: Citations 122021: Citations 142022: Citations 12023: Citations 12024: Citations 32025: Citations 22026: Citations 2

Publication history

01220172018201920202021202220232024202520262017: Publications 12018: Publications 22019: Publications 12020: Publications 12021: Publications 02022: Publications 22023: Publications 02024: Publications 02025: Publications 02026: Publications 0

h-index evolution

Cumulative h-index by year

0134520172018201920202021202220232024202520262017: h-index 22018: h-index 22019: h-index 22020: h-index 32021: h-index 42022: h-index 42023: h-index 42024: h-index 42025: h-index 42026: h-index 4

Most-cited works

  1. Multidrug-resistant tuberculosis in Uzbekistan: results of a nationwide survey, 2010 to 2011201315 citations
  2. A 24-Week, All-Oral Regimen for Rifampin-Resistant Tuberculosis20225 citations
  3. Where there is hope: a qualitative study examining patients’ adherence to multi-drug resistant tuberculosis treatment in Karakalpakstan, Uzbekistan20164 citations
  4. Effectiveness and safety of standardised shorter regimens for multidrug-resistant tuberculosis: individual patient data and aggregate data meta-analyses20174 citations
  5. Modelling the effect of short-course multidrug-resistant tuberculosis treatment in Karakalpakstan, Uzbekistan20163 citations
  6. ‘They prefer hidden treatment': anti-tuberculosis drug-taking practices and drug regulation in Karakalpakstan20162 citations
  7. Revised Definitions of Multidrug-Resistant Tuberculosis Treatment Outcomes: Closer to the Reality?20151 citations
  8. Impact of pyrazinamide resistance on multidrug-resistant tuberculosis in Karakalpakstan, Uzbekistan20181 citations
  9. Standardised shorter regimens <i>versus</i> individualised longer regimens for rifampin- or multidrug-resistant tuberculosis20191 citations
  10. Outcomes with a shorter multidrug-resistant tuberculosis regimen from Karakalpakstan, Uzbekistan20201 citations